Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers

Clinical trial NCT00143741 · COMPLETED

Trial details

NCT number: NCT00143741
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

End-Stage Kidney Disease

Start date: 2005-05-01
Primary completion: 2010-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.